PMCID: PMC7037223 Khavinson VKh, Kuznik BI, Tarnovskaia SI, Lin'kova NS
At 8 mg and 12 mg, the results were dramatic, with the highest dose producing an average 24.2% body weight reduction over 48 weeks
It is also recommended that patients be aware and avoid touching or rubbing the area after treatment
How They Compare Key Considerations Independent mechanisms: GHK-Cu and Tirzepatide work through different receptor systems, reducing interaction risk Complementary goals: GHK-Cu addresses skin anti-aging, wound remodeling, hair growth while Tirzepatide drives weight loss and metabolic improvement Physician supervision required: Any combination protocol should be designed and monitored by a licensed physician Sequential start: Begin one compound first, stabilize, then add the second to identify any individual reactions Frequently Asked Questions Is this combination safe
Anyway, lets look at whats going on together